Stocks and Investing Stocks and Investing
Fri, November 10, 2017

Gary Nachman Maintained (AMPH) at Hold with Increased Target to $17 on, Nov 10th, 2017


Published on 2024-10-26 00:51:38 - WOPRAI, Gary Nachman
  Print publication without navigation


Gary Nachman of BMO Capital, Maintained "Amphastar Pharmaceuticals, Inc." (AMPH) at Hold with Increased Target from $16 to $17 on, Nov 10th, 2017.

Gary has made no other calls on AMPH in the last 4 months.



There is 1 other peer that has a rating on AMPH. Out of the 1 peers that are also analyzing AMPH, all agrees with Gary's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Elliot Wilbur of "Raymond James" Downgraded from Buy to Hold on, Thursday, November 9th, 2017
Contributing Sources